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Litiaza biliară este de două ori mai frecventă la pacienţii care
suferă de ciroză hepatică comparativ cu populaţia totală şi la acei
pacienţi, colecistita acută apare semnificativ mai des. Scopul 
nostru a fost să trecem în revistă literatura de specialitate şi să
prezentăm o privire de ansamblu a indicaţiilor, contraindicaţiilor şi
alternativelor în ciroza cu litiază biliară. Am efectuat o revizuire
sistematică a literaturii folosind cuvintele cheie „ciroză”, „colecis-
tectomie”, „laparoscopie” şi „indicaţii”. Articolele selectate au fost
revizuite pentru informaţii specifice indicaţiilor, contraindicaţiilor
şi alternativelor la colecistectomia laparoscopică în ciroze.
Rezultatele au arătat că colecistectomia laparoscopică poate oferi
mai multe avantaje pentru populaţia cirotică, cu toate acestea 
colecistectomia poate fi provocatoare: indicaţiile specifice şi 
alternativele chirurgicale trebuie discutate de la caz la caz.
Colecistectomia laparoscopică poate fi efectuată în condiţii de 
siguranţă la pacienţii selectaţi cu ciroză; sunt necesare precauţii
speciale în ceea ce priveşte presiunea pneumoperitoneului,
plasarea trocarului şi siguranţa sporită cu colangiografie fluores-
centă verde-indocianină (ICG). Cu toate acestea, la pacienţii 
cirotici cu risc ridicat şi/sau în căile biliare comune litiaza endos-
copică şi non-chirurgicală sunt tratamentele preferate.
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Introduction
Cholelithiasis is found in about one third of
patients with liver cirrhosis (1), about twice as
much as in the overall population (2).
Predisposing factors found in the literature
include gallbladder dysmotility (reduced 
motility and decreased emptying) in the fibrous
transformed liver, reduction in bile acidity,
increased unconjugated bilirubin secretion,
increased levels of estrogen, and increased
intravascular hemolysis due to hypersplenism
(1,3-7). Symptomatic biliary stones in patients
with liver cirrhosis are associated with higher
morbidity (8) and mortality rates than those in
patients with a non-cirrhotic liver (9) and 
in particular when patients with advanced 
cirrhosis undergo surgery (10). Acute cholecys-
titis occurs more often in the cirrhotic: 47% 
versus 14.7% in patients with or without 
cirrhosis, respectively (p<0.001). Our goal was
to review the literature and to overview the
indications, contra-indications, and alterna-
tives in the cirrhotic with biliary stones. 
Methods
We conducted a systematic review of the 
literature using the key words “Cirrhosis”,
“cholecystectomy”, “laparoscopy”, and “indica-
tions”. Of the 136,000 possible references, we
further screened for articles in English and
and published in indexed journals. After 
eliminating redundant publications and 
(second hand) citations, we analyzed 32 articles
(1,3,4,7-35). Selected articles were reviewed for
information specific to laparoscopic cholecystec-
tomy in cirrhotic, indications and contra-
indications and possible alternatives. 
Results
The indications and contra-indications for
laparoscopic cholecystectomy in the cirrhotic
patient and possible alternatives are problems
that all surgeons today may encounter.
Specific indications and contra-indications
must be known before work-up. 
The advantages of laparoscopic cholecystec-
tomy include: minimal tissue trauma and
reduced surgical stress, reduced postoperative
immune suppression, less exposure of viscera,
less fluid and protein loss, less « third sector »
sequestration, less respiratory compromise,
less need for organ luxation, and less 
interruption of the abdominal wall collateral
circulation. 
However, cholecystectomy in the cirrhotic
can be challenging in many aspects leading to
several specific recommendations for laparos-
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copic cholecystectomy in this high-risk group
of patients. 
Alternatives to surgery must be discussed
case by case.
Discussion
Liver cirrhosis increases the difficulty of chole-
cystectomy, particularly in those patients with
severe liver fibrosis (difficulty and fragility in
retraction) and portal hypertension (increased
bleeding). Because of these increased risks,
open cholecystectomy (OC) was originally 
preferred over laparoscopic cholecystectomy
(LC) when surgery became necessary (4,11,12).
Several small series, randomized or not,
have surfaced in the literature as early as
1993 (13), stating that laparoscopic cholecys-
tectomy could be performed safely in selected
patients with cirrhosis (9,11,14), and currently,
laparoscopic cholecystectomy has become the
preferred approach in specific indications
(8,11,15). 
However, the laparoscopic approach has
specific shortcomings in the cirrhotic, and 
special precautions are warranted.
As the hepatic portal inflow in the cirrhotic
is decreased, the hepatic buffer response is
impaired (increased hepatic artery inflow to
compensate the decreased portal inflow).
Because of this, Cobb et al. recommend to 
keep the intra-abdominal pressure as low as
possible, and exsufflate cautiously, intermit-
tently (11). N’Guyen et al. made the following
recommendations (36) ( ).
Several operative details have their impor-
tance. 
1. Operative setup: while it is recognized
that trocars interrupt the collateral 
circulation less than a midline, the peri-
umbilical area should be avoided (37);
2. Once the first trocar is inserted, transil-
lumination of abdominal wall allows to
avoid the collaterals (37); 
3. Placement of subxiphoid port to the right
of the midline avoids injury to the 
falciform ligament and the (potentially
repermeabilized) umbilical vein;
4. If the left lobe encroaches on the opera-
tive field, the surgeon should raise
patient’s right shoulder and/or use a long
port or converter inserted into the 
epigastric port, or if not sufficient, insert
an extra port to retract the left lobe;
5. Intra-operatively, it is essential to avoid
excessive traction on the gallbladder to
avoid avulsion from the liver bed (37);
6. Last, as for other operations in the 
cirrhotic, especially with ascites, intra-
peritoneal drains should be avoided (38).
When the patient is Child C, or MELD >13,
laparoscopic surgery is not recommended and
several alternatives have been suggested such
as partial cholecystectomy (17) or endoscopic
drainage of the gallbladder (21,28), the latter
especially in patients who may someday be
candidates for liver transplantation. In high
risk patients with acute cholecystitis, percuta-
neous cholecystostomy (26,34,39) has been
favored. However, in these patients, the risk of
Pre-operative 
a) Medically optimize the patient: control ascites, correct coagulopathy [fresh frozen plasma (when INR >1.5) and platelets (<50/mm3)] 
b) Cirrhotic patients with hemoglobin <10 g/dL should receive corrective blood transfusions before abdominal surgery
c) Obtain pre-operative imaging to help identify abdominal wall varices or a recanalized umbilical vein and to rule-out hepatoma
d) Consider cholecystostomy tube in patients with Child class C (MELD > 13) (4)
Intra-operative
a) Use the open Hasson approach via an infra-umbilical incision to avoid periumbilical wall varices
b) Transilluminate with the laparoscope to identify vascular collaterals or measure placement based on preoperative imaging
c) If unsuspected cirrhosis is identified during a planned routine laparoscopic cholecystectomy, depending on the experience of the surgeon
and the facilities; consider closing the fascia and skin and transferring the patient to a tertiary medical center with critical care, hepatology,
and hepatobiliary and transplant surgery support
Table 1.
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hemorrhage and/or sepsis in portal hyperten-
sion and/or ascites is high. This has led to a
debate as to whether the transhepatic or
transperitoneal route should be used. 
The transhepatic route preferred by many
because it minimizes the risk of intraperi-
toneal bile leak, inadvertent injury to the
hepatic flexure of the colon (27) [colon 
positioned between skin and gallbladder 
fundus in 13% of patients (33)]. 
In order to facilitate visualization of biliary
structures and to reduce time to get the 
critical view of safety, indocyanine green 
fluorescent cholangiography has been intro-
duced in clinical practice as a promising tool.
Recently, a randomized control trial (40)
demonstrated that this technique is statisti-
cally significantly superior to standard 
technique visualizing extrahepatic biliary
structures during laparoscopic cholecystectomy.
However, a pre-existing liver disease was an
exclusion criterion from this study. According
to literature, no studies stating the feasibility
of indocyanine green (ICG) fluorescent cholan-
giography in cirrhotic patients are available.
ICG can be already used to assess portal
hypertension and esophageal varices in patient
with compensated liver cirrhosis (Child A) (41)
and to estimate short term survival in 
decompensated cirrhosis thorough the ICG
elimination test (42,43). One of the clinical
applications of ICG (44) in fluorescence guided
hepatobiliary surgery is liver mapping. Aoki et
al (45) reported no significant differences in
the mapping of the liver segments between
non-cirrhotic and cirrhotic patients using ICG
fluorescence. Taking into account these 
clinical applications and results, feasibility
studies are necessary to determine the use of
ICG fluorescence cholangiography and or
near-infrared cholecystocholangiography with
direct intra-gallbladder indocyanine green
injection (46).
In patients with CBD stones, the risk of
morbidity and mortality is high, ranging from
2 to 30-50% (16,18,23,24,30). In this setting,
endoscopic management is preferred (18,19,
30) although mortality is still around 15%
(18,31) (vs. overall complication rate of about
10% and a mortality rate of 0.5% in non-
cirrhotics) (20,35). Endoscopic papillary 
balloon dilatation without sphincterotomy is
associated with a lower risk of bleeding but is
of limited efficacy in case of large stones (32).
Endoscopic treatment with mechanical litho-
tripsy or sphincterotomy is recommended for
larger stones (32).
Conclusions
Laparoscopic cholecystectomy could be per-
formed safely in selected patients with cirrhosis.
Special precautions are requested regarding
pneumoperitoneum pressure, trocar placement
and the use of ICG fluorescence intraoperative
cholangiography to increase safety during bile
ducts dissection.
Nevertheless in high-risk cirrothic patients
(Child C, severe ascites) and/or in patients 
suffering from gallbladder and CBD stones,
endoscopic and non-surgical conservative
treatments are recommended. 
No conflicts of interes.
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